市場調査レポート

商品コード

1447814

無針ドラッグデリバリー機器の世界市場規模、シェア、成長分析、技術別、エンドユーザー別-産業予測、2024～2031年

Global Needle-free Drug Delivery Devices Market Size, Share, Growth Analysis, By Technology(Jet injectors, Transdermal patches), By End-user(Hospitals and Clinics to Home Healthcare Settings) - Industry Forecast 2024-2031

出版日: 2024年02月27日 | 発行: SkyQuest

| ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 836,870円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 978,980円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,121,090円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.90円

全表示
概要
目次

概要

サンプル依頼リストに入れる

無針ドラッグデリバリー機器の世界市場規模は2022年に139億9,000万米ドルと評価され、予測期間（2024～2031年）のCAGRは6.8%で、2023年の149億4,000万米ドルから2031年には252億9,000万米ドルに成長する展望です。

世界の無針ドラッグデリバリー機器市場は、医療業界に革命を起こす可能性を秘めており、大きな成長期を迎えています。これらの機器は、薬剤投与における従来の針の使用を排除することで、リスクを軽減し、患者の苦痛を取り除きます。医療セグメントでは、特に自己免疫疾患や糖尿病などの慢性疾患に対して、痛みを伴わない薬剤投与方法に対する需要が高まっています。この需要は、自己注射薬のニーズや高齢者人口の増加とともに、市場拡大の原動力となっています。経皮パッチやジェット注射器などの革新的技術が開発され、その精度と利便性により市場拡大に大きく貢献しています。医療施設では、患者の快適性とコンプライアンスを優先してこれらの機器の導入が進んでいるが、在宅ケアの現場でも導入が進んでいます。吸入式ドラッグデリバリー機器システムやジェットインジェクター、経皮パッチなどの新技術が市場に参入しており、患者の快適性とケアに重点を置いた針を使わないドラッグデリバリー機器の需要に応えています。しかし、高い開発コストや規制上の問題といった課題は、市場の成長を妨げる可能性があります。世界の医療セクターの継続的な進化は、無針ドラッグデリバリー機器市場の継続的な拡大を保証し、ドラッグデリバリー機器の効率向上と患者ケアの強化の可能性を提供します。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

無針ドラッグデリバリー機器の世界市場：技術別

市場概要
ジェットインジェクター
経皮パッチ
吸入ベースのシステム

無針ドラッグデリバリー機器の世界市場：エンドユーザー別

市場概要
病院・クリニックから在宅医療

無針ドラッグデリバリー機器の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Becton, Dickinson and Company（BD）（米国）
Zogenix（米国）
Pfizer Inc.（米国）
Bespak Europe Ltd.（英国、AptarGroupの子会社）
Janssen Pharmaceuticals（ベルギー、Johnson & Johnsonの子会社）
PharmaJet（米国）
3M（米国）
National Medical Products Inc.（NMP Pharma）（米国）
Antares Pharma（米国）
Crossject（フランス）
Novartis AG（スイス）
Bioject Medical Technologies Inc.（米国）
Pharmajet（米国）
Astrazeneca（英国）
Eli Lilly and Company（米国）
MedImmune（米国、AstraZenecaの子会社）
Genentech（米国、Rocheの子会社）
Inovio Pharmaceuticals（米国）
Valeritas（米国）

Product Code: SQMIG35I2250

Global Needle-Free Drug Delivery Devices Market size was valued at USD 13.99 Billion in 2022 and is poised to grow from USD 14.94 Billion in 2023 to USD 25.29 Billion by 2031, at a CAGR of 6.8% during the forecast period (2024-2031).

The global needle-free drug delivery devices market has the potential to revolutionize the healthcare industry, marking a significant period of growth. These devices eliminate the use of traditional needles in administering medication, thereby reducing risks and eliminating patient pain. There is a growing demand in the healthcare sector for pain-free methods of drug administration, especially for chronic conditions like autoimmune disorders and diabetes. This demand, along with the need for self-injected medications and the rising elderly population, is driving market expansion. Innovative technologies such as transdermal patches and jet injectors have been developed, contributing significantly to market growth due to their precision and convenience. Healthcare facilities have been leading in adopting these devices to prioritize patient comfort and compliance, though homecare settings are also increasingly adopting them. New technologies like inhalable drug delivery systems, along with jet injectors and transdermal patches, are entering the market, meeting the demand for needle-free drug delivery driven by a focus on patient comfort and care. However, challenges such as high development costs and regulatory issues could hinder market growth. The ongoing evolution of the global healthcare sector ensures the continued expansion of the needle-free drug delivery devices market, offering the potential to improve drug delivery efficiency and enhance patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Needle-Free Drug Delivery Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Needle-Free Drug Delivery Devices Market Segmental Analysis

Inhalation-based systems, transdermal patches, and jet injector come under the market segment of technology. The major regions in this market are North America, Europe, and Asia-Pacific. The market's end-users include hospitals, clinics, and home healthcare settings.

Drivers of the Global Needle-Free Drug Delivery Devices Market

Technological Advancements: The market has witnessed the introduction of new, highly efficient devices due to continuous enhancements in needle-free drug delivery technology. This progress has enabled the development of advanced tools such as transdermal patches, micro-needles, and jet injectors. These cutting-edge technologies are applicable across various scenarios, with their precision increasing as technology advances.

Enhanced Patient Comfort and Convenience: Unlike traditional injections, which can be painful and carry infection risks, the needle-free drug delivery devices market offers products that are more convenient and less painful. This has led to a significant increase in their usage. Patients with chronic illnesses, who require frequent drug administration, are increasingly preferring these products over conventional methods. As a result, patients are more comfortable continuing their treatments, leading to improved compliance and better treatment outcomes. This improvement in patient care and adherence is a key driver of market growth.

Restraints in the Global Needle-Free Drug Delivery Devices Market

Regulatory Hurdles: The medical device industry, including needle-free drug delivery products, is subject to stringent regulations. The approval process, essential for patient safety and injection effectiveness, can be prolonged and complex. While necessary, these regulations pose challenges. Complying with standards and awaiting approvals can inflate development costs and postpone production and distribution.

Financial Challenges: Needle-free devices can incur significant expenses compared to traditional syringes. These higher costs may impede adoption, particularly in facilities with limited budgets or scarce financial resources. Healthcare centers cannot rely on reimbursement policies to cover the entire cost of these devices, further limiting their accessibility to patients who may benefit from them.

Market Trends of the Global Needle-Free Drug Delivery Devices Market

Expansion of Healthcare Applications: A significant trend observed in the market is the broadening scope of drug delivery devices without needles. These devices are now utilized beyond traditional insulin and vaccine delivery, extending to specialized therapeutics and biologics. Technological advancements have facilitated this expansion into additional applications. With the ongoing need for precise and controlled drug administration, further innovations and applications are anticipated in the market.

Rising Demand for Pain-Free Drug Administration: There is a notable shift away from traditional needle-based injections as consumers increasingly prefer needle-free drug delivery devices. This demand for painless options in drug administration is particularly prevalent among patients with chronic illnesses. This shift has spurred the demand for needle-free tools such as transdermal patches and jet injectors, which can deliver medication directly without causing needle-related pain.

Technological Progress: The needle-free drug delivery industry is experiencing continuous technological innovation, a significant market trend. This ongoing innovation has led to major improvements in product design, enhancing precision and usability to ensure patient compliance. Additionally, advancements have enabled these devices to deliver higher volumes or more viscous medications, making them suitable for a wide range of medications and administration needs.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Needle-free Drug Delivery Devices Market by Technology

Market Overview
Jet injectors
Transdermal patches
and Inhalation-based systems

Global Needle-free Drug Delivery Devices Market by End-user

Market Overview
Hospitals and Clinics to Home Healthcare Settings

Global Needle-free Drug Delivery Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zogenix (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bespak Europe Ltd. (UK, a subsidiary of AptarGroup)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Janssen Pharmaceuticals (Belgium, subsidiary of Johnson & Johnson)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PharmaJet (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
National Medical Products Inc. (NMP Pharma) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Antares Pharma (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Crossject (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioject Medical Technologies Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmajet (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astrazeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MedImmune (USA, a subsidiary of AstraZeneca)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genentech (USA, a subsidiary of Roche)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inovio Pharmaceuticals (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Valeritas (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments